• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

wound

  1. Bye, bye Negative Pressure Sales Team

    Medela cut the entire negative pressure sales force yesterday, save for four reps nationwide who will act in a hybrid role feeling out opportunities. Managers basically demoted to glorified remote rep roles, since they have no direct reports and are lucky to still be retained at all. Marketing...